Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SerpinPC Safety, Tolerability and PK in Healthy Volunteers and Hemophilia A or B Patients
NCT04073498Phase 2Completed
- Sponsor
- ApcinteX Ltd.
- Start
- Aug 2019
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of serpinpc in hemophilia A, hemophilia B (HB), sponsored by ApcinteX Ltd.. Started Aug 2019; status: completed.
02
Drugs
serpinpc
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT04073498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04073498.